Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Quantity: 10mg per vial
These events were generally mild to moderate in severity and included: Nausea often accompanying changes in bowel habits, particularly after dose escalation Diarrhoea loose or watery stools, sometimes with urgency Vomiting less common but reported, especially at higher doses Constipation occurring in some individuals, reflecting the variable effect on gut motility Abdominal discomfort or bloating a sensation of fullness or cramping Flatulence increased wind, which can accompany altered digestion Gastrointestinal adverse events were the most common reason for discontinuation in the Phase 2 trial, occurring in approximately 510% of participants depending on dose group
We partner with you to manage your personalized titration schedule, monitor your progress, and help you maximize the health benefits of your treatment in a safe and supportive environment
Why Medical Supervision Matters BPC-157 and TB-500 are often sold online as research peptides or research chemicals. These products may not be intended for human use and may carry risks related to purity, contamination, incorrect dosing, mislabeling, or unsafe administration
Here is the science behind the time warp, plus gentle ways to steady yourself
Newer incretin-based therapies may offer additional efficacy for selected patients
US$ 21.04
US$ 29.79
US$ 27.50
